Powder: -20°C for 3 years | In solvent: -80°C for 1 year
I-BET567 是一种有效、具有口服活性的泛BET 候选抑制剂,对 BRD4 BD1 和 BD2 的pIC50s 分别为 6.9 和 7.2。I-BET567 在肿瘤和炎症的小鼠模型中已被证明有效。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 2,390 | 现货 | ||
5 mg | ¥ 5,760 | 现货 | ||
10 mg | ¥ 7,860 | 现货 | ||
25 mg | ¥ 11,900 | 现货 | ||
50 mg | ¥ 15,800 | 现货 | ||
100 mg | ¥ 21,600 | 现货 |
产品描述 | I-BET567, a potent pan-BET inhibitor with oral activity, demonstrates pIC50 values of 6.9 and 7.2 for BRD4 BD1 and BD2, respectively. This compound has exhibited efficacy in mouse models of oncology and inflammation [1]. |
体外活性 | I-BET567 (compound 27) (72 hours; 1.5 nM-30 μM) effectively inhibites the proliferation of human NMC cell line 11060 in vitro with an average gpIC 50 6.2 (0.63 μM) [1]. Cell Viability Assay [1] Cell Line: NMC line 11060 cells Concentration: 1.5 nM-30 μM Incubation Time: 72 hours Result: Significantly reduced cell growth. |
体内活性 | I-BET567 (compound 27) (3, 10, and 30 mg/kg; p.o.; once daily for 20 days) causes a significant reduction in tumor growth compared with vehicle controls at both 10 and 30 mg/kg [1]. Assessment of Pharmacokinetics (PK) profile of I-BET567 following intravenous infusion and oral administration in male wistar han rat and beagle dog a [1]. species dose iv b /po c (mg/kg) CL b (mL/min/kg) CL b,u (mL/min/kg) CL renal (mL/min/kg) V ss (L/kg) V ss,u (L/kg) t 1/2 (h) Fpo (%) f ub rat 1.3/3 25 109 7 2.4 10.4 1.6 99 d 0.23 dog 1.0/3 8.1 20 6.9 1.2 2.9 1.8 98 0.41 a: Values are mean, n=3 unless otherwise stated. b: IV dose 1h infusion in DMSO and (10%, w/v) Kleptose HPB in saline (2%: 98% (v/v)). c: PO dose vehicle: 1%(w/v) methycellulose (400 cps) (aq). d: Mean n = 2. Animal Model: NMC 11060 xenograft mouse model (NOD/SCID mouse; bearing NMC 11060 cells) [1] Dosage: 3, 10, and 30 mg/kg Administration: p.o. (once daily for 20 days Result: Led to a significant reduction in tumor growth compared to vehicle controls at both 10 and 30 mg/kg. |
分子量 | 359.81 |
分子式 | C17H18ClN5O2 |
CAS No. | 1887237-54-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
I-BET567 1887237-54-8 I BET567 IBET567 I-BET-567 I-BET 567 Inhibitor inhibitor inhibit